Respiratory syncytial virus (RSV)

Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. For National RSV Awareness Month, learn how Johnson & Johnson is working to keep us all safer from RSV.

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

It’s a lofty goal: improve the health, across the board, of future generations. But it’s a mission that Johnson & Johnson is committed to. And thanks to groundbreaking work taking place across the company—from vaccine development to consumer product innovation—the future is looking very bright.

Bringing your passion to work has taken on new meaning for these inspiring Johnson & Johnson researchers.

These up-and-coming stars in oncology, immunology, anti-aging, vaccines and other areas of research are helping to change healthcare as we know it. And they’re just at the beginning of their brilliant careers.

Sixty-four million people contract RSV each year—yet most people have never even heard of it. As peak infection season approaches, here’s a handy primer on respiratory syncytial virus.